Skip to main content
ANIK logo

ANIK · Anika Therapeutics, Inc. · Documents

Track ANIK — free
$13.62 +0.77 (+5.99%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$182.44M
Shares
13.40M
Volume · Nov 18 119.01K Avg daily vol (3M) 107.13K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2021
May 7
Quarterly report 10-Q FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $34.29M ▼ 3.1% Net income $2.84M ▼ 51.0% Diluted EPS $0.20 ▼ 50.0%
Apr 26
Annual report 10-K/A FY2020, ended Dec 31
Annual report for FY2020
Revenue $130.46M ▲ 13.8% Net loss $23.98M Diluted EPS -$1.69
Mar 5
Annual report 10-K FY2020, ended Dec 31
Annual report for FY2020
Revenue $130.46M ▲ 13.8% Net loss $23.98M Diluted EPS -$1.69
2020
May 22
Quarterly report 10-Q FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $35.4M ▲ 43.2% Net income $5.79M ▲ 28.5% Diluted EPS $0.40 ▲ 29.0%
Mar 6
Annual report 10-K FY2019, ended Dec 31
Annual report for FY2019
Revenue $114.61M ▲ 8.6% Net income $27.19M ▲ 45.2% Diluted EPS $1.89 ▲ 48.8%
Showing 101–150 of 150 documents
Key facts CIK 898437 CUSIP 035255108 13F (30d) 141 filings 126 filers Visit website Investor relations